packageMobocertinib

mobocertinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Mobocertinib is an EGFR tyrosine kinase inhibitor developed for treating non-small-cell lung cancer. It is no longer available: its marketing application in the European Union was withdrawn, and it is listed as withdrawn.

Summary written by glm-5.3-flash from Wikidata Q105338009 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:mobocertinib
ATC codes:L01EB10
DrugBank:DB16390
PubChem CID:118607832
Wikidata:Q105338009
formula:C32H39N7O4
molar mass:585.709 g/mol (PubChem CID 118607832)
logP:4.4 (Drugs.Common 25.09, not verified)

Metabolites

AP32914AP32914molar mass unknown
AP32960AP32960molar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
AP32914metabolite: AP32914
AP32960metabolite: AP32960